An investigator from MGH and the CSO of Inozyme discuss p1 data at Kidney Week showing that INZ-701 raised the levels of inorganic pyrophosphate, making it a possible treatment for calciphylaxis

Sagar Nigwekar and Yves Sabbagh describe the problem of calciphylaxis, and why they believe that raising the levels of PPi could have an impact on it. The next step will be to meet with FDA about designing a trial for these patients specifically.